<?xml version="1.0" encoding="UTF-8"?>





<rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0">


 





 










 








	 	 
<channel>
<title>CROI 2014  - CROI 2014</title>
<itunes:author>CROI</itunes:author>
<description>CROI 2014  - CROI 2014</description>
<itunes:summary>CROI 2014  - CROI 2014</itunes:summary>    
<link>http://www.croiconference.org/</link>
<language>en-us</language>
<copyright>Copyright 2014, CROI. All Rights Reserved.</copyright>
<itunes:category>Podcasts</itunes:category>
 
         
<webMaster>support@capitalreach.com</webMaster>
 
        
  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22002.mp3?mediaType=feedmp3</link>
<description>
"Convener" by John W. Mellors of University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
"Convener" by Judith S. Currier of University of California Los Angeles, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22002.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22002.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"Convener" by John W. Mellors of University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
"Convener" by Judith S. Currier of University of California Los Angeles, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22003.mp3?mediaType=feedmp3</link>
<description>
"HIV Pathogenesis: Current Understanding and Future Research" by Dana H. Gabuzda of Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22003.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22003.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"HIV Pathogenesis: Current Understanding and Future Research" by Dana H. Gabuzda of Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22004.mp3?mediaType=feedmp3</link>
<description>
"HIV Cure Research" by John W. Mellors of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22004.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22004.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"HIV Cure Research" by John W. Mellors of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22005.mp3?mediaType=feedmp3</link>
<description>
"HIV Vaccine Immunology: Recent Progress and Continuing Challenges" by Richard A. Koup of Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22005.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22005.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"HIV Vaccine Immunology: Recent Progress and Continuing Challenges" by Richard A. Koup of Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22006.mp3?mediaType=feedmp3</link>
<description>
"HIV Prevention Research: Progress and Challenges" by Sharon L. Hillier of University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22006.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22006.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"HIV Prevention Research: Progress and Challenges" by Sharon L. Hillier of University of Pittsburgh School of Medicine, Magee-Womens Hospital, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Program Committee Workshop for New Investigators and Trainees</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22007.mp3?mediaType=feedmp3</link>
<description>
"Pathogenesis and Control of HCV Infection" by David L. Thomas of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22007.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22007.mp3</guid>	
 
<itunes:summary>Workshop: Program Committee Workshop for New Investigators and Trainees

"Pathogenesis and Control of HCV Infection" by David L. Thomas of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Martin Delaney Panel: Hepatitis C Virus: From Trials and Tribulation to Triumph</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22009.mp3?mediaType=feedmp3</link>
<description>
"Introduction" by Michael Marco of Columbia University School of Public Health, New York, NY, United States
"Panel Leader" by Jeff Taylor of AIDS Treatment Activists Coalition, Palm Springs, CA, United States
"Panel Leader" by Tracy Swan of Treatment Action Group, New York, NY, United States
"Panelist" by Isabelle Andrieux-Meyer of Médecins sans Frontières, Geneva, Switzerland
"Panelist" by Jules Levin of National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
"Panelist" by Lynn E. Taylor of Brown University, Providence, RI, United States
"Wrap-up" by Jules Levin of National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22009.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22009.mp3</guid>	
 
<itunes:summary>Martin Delaney Panel: Hepatitis C Virus: From Trials and Tribulation to Triumph

"Introduction" by Michael Marco of Columbia University School of Public Health, New York, NY, United States
"Panel Leader" by Jeff Taylor of AIDS Treatment Activists Coalition, Palm Springs, CA, United States
"Panel Leader" by Tracy Swan of Treatment Action Group, New York, NY, United States
"Panelist" by Isabelle Andrieux-Meyer of Médecins sans Frontières, Geneva, Switzerland
"Panelist" by Jules Levin of National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
"Panelist" by Lynn E. Taylor of Brown University, Providence, RI, United States
"Wrap-up" by Jules Levin of National AIDS Treatment Advocacy Project (NATAP), New York, NY, United States
"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Clinical Trial Design and Analysis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22017.mp3?mediaType=feedmp3</link>
<description>
"Adherence: The Achilles Heel for Trial Interventions" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22017.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22017.mp3</guid>	
 
<itunes:summary>Workshop: Clinical Trial Design and Analysis

"Adherence: The Achilles Heel for Trial Interventions" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Clinical Trial Design and Analysis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22018.mp3?mediaType=feedmp3</link>
<description>
"Studying Multiple Interventions: Factorial Designs and Other Approaches" by Richard J. Hayes of London School of Hygiene and Tropical Medicine, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22018.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22018.mp3</guid>	
 
<itunes:summary>Workshop: Clinical Trial Design and Analysis

"Studying Multiple Interventions: Factorial Designs and Other Approaches" by Richard J. Hayes of London School of Hygiene and Tropical Medicine, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Clinical Trial Design and Analysis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22019.mp3?mediaType=feedmp3</link>
<description>
"So Many Trials, So Little Time: Meta-Analysis Dos and Don’ts" by Dean A. Follmann of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22019.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22019.mp3</guid>	
 
<itunes:summary>Workshop: Clinical Trial Design and Analysis

"So Many Trials, So Little Time: Meta-Analysis Dos and Don’ts" by Dean A. Follmann of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Frontiers in Laboratory Science Workshop</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22023.mp3?mediaType=feedmp3</link>
<description>
"Systems Immunology Approaches for Vaccine Profiling and Antibody Discovery" by Sai Reddy of Swiss Federal Institute of Technology Zurich, Basel, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22023.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22023.mp3</guid>	
 
<itunes:summary>Workshop: Frontiers in Laboratory Science Workshop

"Systems Immunology Approaches for Vaccine Profiling and Antibody Discovery" by Sai Reddy of Swiss Federal Institute of Technology Zurich, Basel, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Frontiers in Laboratory Science Workshop</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22024.mp3?mediaType=feedmp3</link>
<description>
"3-D Structural Analysis of HIV Using Correlative CryoEM and Live Cell Imaging" by Peijun Zhang of University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22024.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22024.mp3</guid>	
 
<itunes:summary>Workshop: Frontiers in Laboratory Science Workshop

"3-D Structural Analysis of HIV Using Correlative CryoEM and Live Cell Imaging" by Peijun Zhang of University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Frontiers in Laboratory Science Workshop</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22025.mp3?mediaType=feedmp3</link>
<description>
"Virus-Host Interactions Revealed Through Proteomics/Phosphoproteomics" by Beatrix Ueberheide of New York University Langone Medical Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22025.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22025.mp3</guid>	
 
<itunes:summary>Workshop: Frontiers in Laboratory Science Workshop

"Virus-Host Interactions Revealed Through Proteomics/Phosphoproteomics" by Beatrix Ueberheide of New York University Langone Medical Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Frontiers in Laboratory Science Workshop</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22026.mp3?mediaType=feedmp3</link>
<description>
"CRISPRs and Other Genome Editing Systems" by Paul F. Bates of University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22026.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22026.mp3</guid>	
 
<itunes:summary>Workshop: Frontiers in Laboratory Science Workshop

"CRISPRs and Other Genome Editing Systems" by Paul F. Bates of University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22029.mp3?mediaType=feedmp3</link>
<description>
"Convener" by Robert T. Schooley of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22029.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22029.mp3</guid>	
 
<itunes:summary>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session

"Convener" by Robert T. Schooley of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22030.mp3?mediaType=feedmp3</link>
<description>
"Liver Management" by Kenneth E. Sherman of University of Cincinnati College of Medicine, Cincinnati, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22030.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22030.mp3</guid>	
 
<itunes:summary>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session

"Liver Management" by Kenneth E. Sherman of University of Cincinnati College of Medicine, Cincinnati, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22031.mp3?mediaType=feedmp3</link>
<description>
"Interactive Case Presentations" by David L. Wyles of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22031.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22031.mp3</guid>	
 
<itunes:summary>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session

"Interactive Case Presentations" by David L. Wyles of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22032.mp3?mediaType=feedmp3</link>
<description>
"Interactive Case Presentations" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22032.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22032.mp3</guid>	
 
<itunes:summary>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session

"Interactive Case Presentations" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22033.mp3?mediaType=feedmp3</link>
<description>
"Interactive Case Presentations" by David L. Wyles of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22033.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22033.mp3</guid>	
 
<itunes:summary>Workshop: Workshop for Clinicians Who Are New to Hepatitis C Management: A Case-Based Interactive Session

"Interactive Case Presentations" by David L. Wyles of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Opening Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22034.mp3?mediaType=feedmp3</link>
<description>
"Introduction" by Kevin M. De Cock of Centers for Disease Control and Prevention, Nairobi, Kenya 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22034.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22034.mp3</guid>	
 
<itunes:summary>Opening Session

"Introduction" by Kevin M. De Cock of Centers for Disease Control and Prevention, Nairobi, Kenya 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Opening Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22035.mp3?mediaType=feedmp3</link>
<description>
"Bernard Fields Lecture: Making and Breaking Barriers To Cross-Species HIV-1 Transmission" by Paul D. Bieniasz of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22035.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22035.mp3</guid>	
 
<itunes:summary>Opening Session

"Bernard Fields Lecture: Making and Breaking Barriers To Cross-Species HIV-1 Transmission" by Paul D. Bieniasz of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Opening Session</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22036.mp3?mediaType=feedmp3</link>
<description>
"N'Galy-Mann Lecture: Application of Scientific Knowledge and Evidence To Limit the Progression of HIV/AIDS and Fight Other Endemic Diseases in West Africa" by Souleymane Mboup of Centre Hospitalier Universitaire Aristide le Dantec, Dakar, Senegal
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22036.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22036.mp3</guid>	
 
<itunes:summary>Opening Session

"N'Galy-Mann Lecture: Application of Scientific Knowledge and Evidence To Limit the Progression of HIV/AIDS and Fight Other Endemic Diseases in West Africa" by Souleymane Mboup of Centre Hospitalier Universitaire Aristide le Dantec, Dakar, Senegal

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: HPV Vaccines: Progress To Date and Future Worldwide Directions</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22038.mp3?mediaType=feedmp3</link>
<description>
"HPV Vaccines: Progress To Date and Future Worldwide Directions" by Douglas R. Lowy of National Cancer Institute, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22038.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22038.mp3</guid>	
 
<itunes:summary>Plenary: HPV Vaccines: Progress To Date and Future Worldwide Directions

"HPV Vaccines: Progress To Date and Future Worldwide Directions" by Douglas R. Lowy of National Cancer Institute, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: HIV in People Who Use Drugs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22039.mp3?mediaType=feedmp3</link>
<description>
"HIV in People Who Use Drugs" by Adeeba Kamarulzaman of University of Malaya, Kuala Lumpur, Malaysia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22039.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22039.mp3</guid>	
 
<itunes:summary>Plenary: HIV in People Who Use Drugs

"HIV in People Who Use Drugs" by Adeeba Kamarulzaman of University of Malaya, Kuala Lumpur, Malaysia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22042.mp3?mediaType=feedmp3</link>
<description>
"Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals" by Diana Y. Chen of Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22042.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22042.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Longitudinal Phenotypic Profiling of Early HCV-Specific CD4 T Cells in HIV- and HIV+ Individuals" by Diana Y. Chen of Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22043.mp3?mediaType=feedmp3</link>
<description>
"Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C" by Eric G. Meissner of Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22043.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22043.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Rapid Peripheral In Vivo Cellular Changes During Interferon-Free Treatment of Hepatitis C" by Eric G. Meissner of Laboratory of Immunoregulation, NIAID/NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22044.mp3?mediaType=feedmp3</link>
<description>
"Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4" by Douglas Dieterich of Mount Sinai Medical Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22044.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22044.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Faldaprevir Plus Pegylated Interferon Alfa-2a/Ribavirin in HIV/HCV Coinfection: STARTVerso4" by Douglas Dieterich of Mount Sinai Medical Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22045.mp3?mediaType=feedmp3</link>
<description>
"Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)" by Douglas Dieterich of Icahn School of Medicine at Mount Sinai, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22045.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22045.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Simeprevir (TMC435) Plus PegIFN/Ribavirin in HCV Genotype-1/HIV-1 Coinfection (Study C212)" by Douglas Dieterich of Icahn School of Medicine at Mount Sinai, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22046.mp3?mediaType=feedmp3</link>
<description>
"All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection" by Trevor Hawkins of Southwest CARE Center, Santa Fe, NM, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22046.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22046.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"All-Oral Combination of Daclatasvir, Asunaprevir, and BMS-791325 for HCV Genotype 1 Infection" by Trevor Hawkins of Southwest CARE Center, Santa Fe, NM, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22047.mp3?mediaType=feedmp3</link>
<description>
"Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22047.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22047.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Sofosbuvir Plus Ribavirin for HCV Genotype 1-3 Infection in HIV Coinfected Patients (PHOTON-1)" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22048.mp3?mediaType=feedmp3</link>
<description>
"Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial" by Anita Kohli of Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22048.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22048.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial" by Anita Kohli of Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, United States and Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc. (formerly SAIC–Frederick, Inc.), Frederick National Laboratory for Cancer Research, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22049.mp3?mediaType=feedmp3</link>
<description>
"Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection" by Christophe Hezode of Hôpital Henri Mondor, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22049.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22049.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"Daclatasvir in Combination With Simeprevir ± Ribavirin for Hepatitis C Virus Genotype 1 Infection" by Christophe Hezode of Hôpital Henri Mondor, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Hepatitis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22050.mp3?mediaType=feedmp3</link>
<description>
"PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection" by K Rajender Reddy of University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22050.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22050.mp3</guid>	
 
<itunes:summary>Oral Abstract: Hepatitis

"PEARL III: SVR ≥99% After 12 Wks of ABT-450/r/267 + ABT-333 ± RBV in Treatment Naïve HCV GT1b Infection" by K Rajender Reddy of University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22053.mp3?mediaType=feedmp3</link>
<description>
"Moderator" by Victor G. Valcour of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22053.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22053.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Moderator" by Victor G. Valcour of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22054.mp3?mediaType=feedmp3</link>
<description>
"Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation" by Julia Peterson of Neurology, University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22054.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22054.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Early Antiretroviral Therapy Appears To Normalize Intrathecal Markers of Immune Activation" by Julia Peterson of Neurology, University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22055.mp3?mediaType=feedmp3</link>
<description>
"Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV" by Michael J. Peluso of Department of Medicine, Brigham and Women’s Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22055.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22055.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV" by Michael J. Peluso of Department of Medicine, Brigham and Women’s Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22056.mp3?mediaType=feedmp3</link>
<description>
"Replication of HIV-1 in the Central Nervous System of Adults Early After Infection" by Christa Buckheit Sturdevant of UNC Chapel Hill, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22056.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22056.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Replication of HIV-1 in the Central Nervous System of Adults Early After Infection" by Christa Buckheit Sturdevant of UNC Chapel Hill, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22057.mp3?mediaType=feedmp3</link>
<description>
"Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression" by Edward R. Hammond of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22057.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22057.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Persistent CSF, But Not Plasma HIV RNA Is Associated With Increased Risk of New-Onset Depression" by Edward R. Hammond of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22058.mp3?mediaType=feedmp3</link>
<description>
"CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND" by Edana Cassol of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22058.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22058.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"CSF Metabolomics Reveals Altered Waste Clearance and Accelerated Aging in HIV Patients With HAND" by Edana Cassol of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22059.mp3?mediaType=feedmp3</link>
<description>
"Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects" by Ronald J. Ellis of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22059.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22059.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroHIV: Developments in Treatment and Pathogenesis

"Cerebral Small Vessel Disease and HAND in ARV-Treated Subjects" by Ronald J. Ellis of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22063.mp3?mediaType=feedmp3</link>
<description>
"Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility" by Nikos Pantazis of Hygiene, Epidemiology &amp; Medical Statistics, Athens University Medical School, Athens, Greece
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22063.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22063.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility" by Nikos Pantazis of Hygiene, Epidemiology &amp; Medical Statistics, Athens University Medical School, Athens, Greece

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22064.mp3?mediaType=feedmp3</link>
<description>
"Transmission Clusters, Recent Infection and STIs Among New HIV Cases: Implications for Prevention" by Hong-Ha M. Truong of University of California San Francisco, San Francisco, CA, United States and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22064.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22064.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Transmission Clusters, Recent Infection and STIs Among New HIV Cases: Implications for Prevention" by Hong-Ha M. Truong of University of California San Francisco, San Francisco, CA, United States and Gladstone Institute of Virology and Immunology, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22065.mp3?mediaType=feedmp3</link>
<description>
"Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA" by Eli S. Rosenberg of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22065.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22065.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Race and Age Disparities in HIV Incidence and Prevalence Among MSM in Atlanta, GA" by Eli S. Rosenberg of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22066.mp3?mediaType=feedmp3</link>
<description>
"Correlating GSK1265744 Plasma Levels To Prevention of Rectal SHIV Transmission in Macaques" by Chasity D. Andrews of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22066.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22066.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Correlating GSK1265744 Plasma Levels To Prevention of Rectal SHIV Transmission in Macaques" by Chasity D. Andrews of Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22067.mp3?mediaType=feedmp3</link>
<description>
"Monthly GSK744 Long-Acting Injections Protect Macaques Against Repeated Vaginal SHIV Exposures" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22067.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22067.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Monthly GSK744 Long-Acting Injections Protect Macaques Against Repeated Vaginal SHIV Exposures" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22068.mp3?mediaType=feedmp3</link>
<description>
"Safety and Pharmacokinetics/Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings" by Beatrice A. Chen of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22068.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22068.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Safety and Pharmacokinetics/Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings" by Beatrice A. Chen of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22069.mp3?mediaType=feedmp3</link>
<description>
"FAME-02: A Phase I Trial To Assess Safety, PK, and PD of Gel and Film Formulations of Dapivirine" by Katherine E. Bunge of Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22069.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22069.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"FAME-02: A Phase I Trial To Assess Safety, PK, and PD of Gel and Film Formulations of Dapivirine" by Katherine E. Bunge of Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22070.mp3?mediaType=feedmp3</link>
<description>
"Single-Agent TDF Versus Combination FTC/TDF PrEP Among Heterosexual Men and Women" by Jared Baeten of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22070.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22070.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Single-Agent TDF Versus Combination FTC/TDF PrEP Among Heterosexual Men and Women" by Jared Baeten of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22071.mp3?mediaType=feedmp3</link>
<description>
"Divergent Adherence Estimates With Pharmacokinetic and Behavioral Measures in VOICE (MTN003)" by Ariane van der Straten of Women’s Global Health Imperative, RTI International, San Francisco, CA, United States and Department of Medicine, Center for AIDS Prevention Studies (CAPS), University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22071.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22071.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"Divergent Adherence Estimates With Pharmacokinetic and Behavioral Measures in VOICE (MTN003)" by Ariane van der Straten of Women’s Global Health Imperative, RTI International, San Francisco, CA, United States and Department of Medicine, Center for AIDS Prevention Studies (CAPS), University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention and Epidemiology: Evolving Trends</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22072.mp3?mediaType=feedmp3</link>
<description>
"HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART: PARTNER Study" by Alison Rodger of Research Department of Infection &amp; Population Health, University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22072.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22072.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention and Epidemiology: Evolving Trends

"HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART: PARTNER Study" by Alison Rodger of Research Department of Infection &amp; Population Health, University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22073.mp3?mediaType=feedmp3</link>
<description>
"Summary" by Renate R. Köenig of Paul-Ehrlich-Institut, Langen, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22073.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22073.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Summary" by Renate R. Köenig of Paul-Ehrlich-Institut, Langen, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22075.mp3?mediaType=feedmp3</link>
<description>
"Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1" by Henning Hofmann of NYU School of Medicine, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22075.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22075.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Inhibition of Cul4A Neddylation Causes a Reversible Block To SAMHD1-Mediated Restriction of HIV-1" by Henning Hofmann of NYU School of Medicine, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22076.mp3?mediaType=feedmp3</link>
<description>
"MX2, an Interferon-Induced Inhibitor of HIV-1 Infection" by Melissa Kane of The Rockefeller University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22076.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22076.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"MX2, an Interferon-Induced Inhibitor of HIV-1 Infection" by Melissa Kane of The Rockefeller University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22077.mp3?mediaType=feedmp3</link>
<description>
"BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner" by Ruth Serra-Moreno of Harvard Medical School, Southborough, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22077.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22077.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner" by Ruth Serra-Moreno of Harvard Medical School, Southborough, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22078.mp3?mediaType=feedmp3</link>
<description>
"Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization" by Markus-Frederik Bohn of Biochemistry, UMass Medical School, Worcester, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22078.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22078.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Crystal Structure of APOBEC3F Elucidates HIV-1 Vif Interaction and Dynamic Oligomerization" by Markus-Frederik Bohn of Biochemistry, UMass Medical School, Worcester, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22079.mp3?mediaType=feedmp3</link>
<description>
"Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α" by Owen Pornillos of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22079.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22079.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α" by Owen Pornillos of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22080.mp3?mediaType=feedmp3</link>
<description>
"Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis" by Sebla B. Kutluay of Aaron Diamond AIDS Research Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22080.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22080.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Global Identification of the RNA Targets of HIV-1 Gag During Particle Genesis" by Sebla B. Kutluay of Aaron Diamond AIDS Research Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22081.mp3?mediaType=feedmp3</link>
<description>
"Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors" by Mirela D'arc of Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22081.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22081.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"Gorillas Transmitted SIV To Humans: Identification of HIV-1 Group P and O Ancestors" by Mirela D'arc of Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Host Factors and HIV/SIV Replication</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22082.mp3?mediaType=feedmp3</link>
<description>
"A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)" by Walid Heneine of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22082.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22082.mp3</guid>	
 
<itunes:summary>Oral Abstract: Host Factors and HIV/SIV Replication

"A Gorilla Reservoir for Human T-lymphotropic Virus Type 4 (HTLV-4)" by Walid Heneine of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22084.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Georg M. Lauer of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22084.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22084.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Discussion Leader" by Georg M. Lauer of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22085.mp3?mediaType=feedmp3</link>
<description>
"Seminal HCV RNA Level May Mirror Dynamics of Plasma HCV RNA in HIV-Positive Men With Acute HCV" by Daniel Bradshaw of Kirby Institute, University of New South Wales, Sydney, Australia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22085.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22085.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Seminal HCV RNA Level May Mirror Dynamics of Plasma HCV RNA in HIV-Positive Men With Acute HCV" by Daniel Bradshaw of Kirby Institute, University of New South Wales, Sydney, Australia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22086.mp3?mediaType=feedmp3</link>
<description>
"Higher Risk of Sexually Acquired HCV Coinfection in MSM With Wide HIV Transmission Bottleneck" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22086.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22086.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Higher Risk of Sexually Acquired HCV Coinfection in MSM With Wide HIV Transmission Bottleneck" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22087.mp3?mediaType=feedmp3</link>
<description>
"Assessing HCV Acquisition Routes in HIV-Infected MSM Using Single Genome Sequencing—A Pilot Study" by Daniel S. Fierer of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22087.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22087.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Assessing HCV Acquisition Routes in HIV-Infected MSM Using Single Genome Sequencing—A Pilot Study" by Daniel S. Fierer of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22088.mp3?mediaType=feedmp3</link>
<description>
"CD3+CD56+ Natural Killer-Like T Cells in HIV(+) Patients With Acute Hepatitis C" by Pavlos Kokordelis of Internal Medicine I, University of Bonn, Bonn, Germany and German Center for Infection Research (DZIF), Bonn, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22088.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22088.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"CD3+CD56+ Natural Killer-Like T Cells in HIV(+) Patients With Acute Hepatitis C" by Pavlos Kokordelis of Internal Medicine I, University of Bonn, Bonn, Germany and German Center for Infection Research (DZIF), Bonn, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22089.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22089.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22089.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22090.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Paul W. Spearman of Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22090.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22090.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Discussion Leader" by Paul W. Spearman of Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22091.mp3?mediaType=feedmp3</link>
<description>
"Degradation of SAMHD1 Specifically Decreases the Efficacy of Thymidine HIV RT Analog Inhibitors" by Ester Ballana of IrsiCaixa AIDS Research Institute, Badalona, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22091.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22091.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Degradation of SAMHD1 Specifically Decreases the Efficacy of Thymidine HIV RT Analog Inhibitors" by Ester Ballana of IrsiCaixa AIDS Research Institute, Badalona, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22092.mp3?mediaType=feedmp3</link>
<description>
"Characterizing Novel N-Terminal Domains of APOBEC3G" by Meiling R. May of College of the Holy Cross, Worcester, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22092.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22092.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Characterizing Novel N-Terminal Domains of APOBEC3G" by Meiling R. May of College of the Holy Cross, Worcester, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22093.mp3?mediaType=feedmp3</link>
<description>
"Natural Resistance To HIV-1 by Select APOBEC3H Haplotypes" by Eric W. Refsland of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22093.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22093.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Natural Resistance To HIV-1 by Select APOBEC3H Haplotypes" by Eric W. Refsland of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22094.mp3?mediaType=feedmp3</link>
<description>
"Nuclear Import of APOBEC3F-Labeled HIV-1 Preintegration Complexes" by Vinay K. Pathak of HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22094.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22094.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Nuclear Import of APOBEC3F-Labeled HIV-1 Preintegration Complexes" by Vinay K. Pathak of HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22095.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22095.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22095.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22096.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Wendy S. Post of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22096.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22096.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Discussion Leader" by Wendy S. Post of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22097.mp3?mediaType=feedmp3</link>
<description>
"ST2 and GDF-15 Are Associated With Structural Heart Disease and Mortality in HIV" by Eric Secemsky of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22097.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22097.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"ST2 and GDF-15 Are Associated With Structural Heart Disease and Mortality in HIV" by Eric Secemsky of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22098.mp3?mediaType=feedmp3</link>
<description>
"Elevated NT-proBNP Levels Predict Mortality in HIV-Infected Women" by Matthew R. Gingo of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22098.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22098.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Elevated NT-proBNP Levels Predict Mortality in HIV-Infected Women" by Matthew R. Gingo of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22099.mp3?mediaType=feedmp3</link>
<description>
"Depression and HIV Are Risk Factors for Incident Heart Failure Among Veterans" by Jessica R. White of University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22099.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22099.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Depression and HIV Are Risk Factors for Incident Heart Failure Among Veterans" by Jessica R. White of University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22100.mp3?mediaType=feedmp3</link>
<description>
"Cardiac Steatosis Increased in HIV: Related To Gender, Visceral Fat and ARV Exposure" by Julia B. Purdy of Critical Care Medicine, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22100.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22100.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Cardiac Steatosis Increased in HIV: Related To Gender, Visceral Fat and ARV Exposure" by Julia B. Purdy of Critical Care Medicine, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22101.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22101.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22101.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22102.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Mark F. Cotton of Stellenbosch University, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22102.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22102.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Discussion Leader" by Mark F. Cotton of Stellenbosch University, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22103.mp3?mediaType=feedmp3</link>
<description>
"Routine Antibody Tests Have No Place in Determining HIV Status After Early ART: Evidence From CHER" by Helen Payne of Infectious Diseases and Microbiology, Institute of Child Health, London, United Kingdom and Children’s Infectious Diseases Clinical Research Unit, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22103.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22103.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Routine Antibody Tests Have No Place in Determining HIV Status After Early ART: Evidence From CHER" by Helen Payne of Infectious Diseases and Microbiology, Institute of Child Health, London, United Kingdom and Children’s Infectious Diseases Clinical Research Unit, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22104.mp3?mediaType=feedmp3</link>
<description>
"Different Profiles of HIV in Early Treated HIV-Infected Children Seronegative by ELISA in Cameroon" by Mathurin C. Tejiokem of Service d’Épidémiologie et de Santé Publique, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroon
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22104.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22104.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Different Profiles of HIV in Early Treated HIV-Infected Children Seronegative by ELISA in Cameroon" by Mathurin C. Tejiokem of Service d’Épidémiologie et de Santé Publique, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroon

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22105.mp3?mediaType=feedmp3</link>
<description>
"Greater Virologic Control in Infants Initiated On ART Before 6 Months of Age" by Stephanie Shiau of Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22105.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22105.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Greater Virologic Control in Infants Initiated On ART Before 6 Months of Age" by Stephanie Shiau of Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22106.mp3?mediaType=feedmp3</link>
<description>
"Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children" by Claudia S. Crowell of Pediatrics, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22106.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22106.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children" by Claudia S. Crowell of Pediatrics, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22107.mp3?mediaType=feedmp3</link>
<description>
"Early Cytomegalovirus Viraemia and Clinical Outcomes of HIV-Infected Children in the Early ART Era" by Nei-yuan Hsiao of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22107.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22107.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Early Cytomegalovirus Viraemia and Clinical Outcomes of HIV-Infected Children in the Early ART Era" by Nei-yuan Hsiao of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22108.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22108.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22108.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22109.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22109.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22109.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Discussion Leader" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22110.mp3?mediaType=feedmp3</link>
<description>
"Comparative Effectiveness of HIV Care and Treatment Programs in East Africa" by Elvin Geng of Medicine, University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22110.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22110.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Comparative Effectiveness of HIV Care and Treatment Programs in East Africa" by Elvin Geng of Medicine, University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22111.mp3?mediaType=feedmp3</link>
<description>
"HIV Care Cascade Among Hard To Reach Populations in India: Need To Expand HIV Counseling and Testing" by Shruti H. Mehta of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22111.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22111.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"HIV Care Cascade Among Hard To Reach Populations in India: Need To Expand HIV Counseling and Testing" by Shruti H. Mehta of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22112.mp3?mediaType=feedmp3</link>
<description>
"Loss To Follow-up: Determining Outcomes for Adults Enrolled in HIV Services in Kenya" by William Reidy of Mailman School of Public Health, ICAP-Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22112.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22112.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Loss To Follow-up: Determining Outcomes for Adults Enrolled in HIV Services in Kenya" by William Reidy of Mailman School of Public Health, ICAP-Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22113.mp3?mediaType=feedmp3</link>
<description>
"Unplanned Interruptions in HIV Care in Nigeria: Rates and Implications" by Aima A. Ahonkhai of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22113.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22113.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Unplanned Interruptions in HIV Care in Nigeria: Rates and Implications" by Aima A. Ahonkhai of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22114.mp3?mediaType=feedmp3</link>
<description>
"Using the Side Door: Non-Linear Patterns Within the HIV Treatment Cascade in Zambia" by Charles B. Holmes of Centre for Infectious Disease Research in Zambia, Lusaka, Zambia and University of North Carolina School of Medicine, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22114.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22114.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Using the Side Door: Non-Linear Patterns Within the HIV Treatment Cascade in Zambia" by Charles B. Holmes of Centre for Infectious Disease Research in Zambia, Lusaka, Zambia and University of North Carolina School of Medicine, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22115.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22115.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22115.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Toward a Cure: A Challenging Game of Hide and Seek</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22116.mp3?mediaType=feedmp3</link>
<description>
"Convener" by Christine Rouzioux of Université Paris Descartes, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22116.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22116.mp3</guid>	
 
<itunes:summary>Symposium: Toward a Cure: A Challenging Game of Hide and Seek

"Convener" by Christine Rouzioux of Université Paris Descartes, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Toward a Cure: A Challenging Game of Hide and Seek</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22118.mp3?mediaType=feedmp3</link>
<description>
"Impact of Early ART On HIV Eradication in Children" by Katherine F. Luzuriaga of University of Massachusetts Medical School, Worcester, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22118.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22118.mp3</guid>	
 
<itunes:summary>Symposium: Toward a Cure: A Challenging Game of Hide and Seek

"Impact of Early ART On HIV Eradication in Children" by Katherine F. Luzuriaga of University of Massachusetts Medical School, Worcester, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Toward a Cure: A Challenging Game of Hide and Seek</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22119.mp3?mediaType=feedmp3</link>
<description>
"T Memory Stem Cells: The Stem Cell Reservoir for HIV?" by Mathias Lichterfeld of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22119.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22119.mp3</guid>	
 
<itunes:summary>Symposium: Toward a Cure: A Challenging Game of Hide and Seek

"T Memory Stem Cells: The Stem Cell Reservoir for HIV?" by Mathias Lichterfeld of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Toward a Cure: A Challenging Game of Hide and Seek</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22120.mp3?mediaType=feedmp3</link>
<description>
"Inflammation as an Obstacle for Remission: Lessons Learned From Non-Human Primate Models" by Michaela Müller-Trutwin of Institut Pasteur, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22120.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22120.mp3</guid>	
 
<itunes:summary>Symposium: Toward a Cure: A Challenging Game of Hide and Seek

"Inflammation as an Obstacle for Remission: Lessons Learned From Non-Human Primate Models" by Michaela Müller-Trutwin of Institut Pasteur, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Toward a Cure: A Challenging Game of Hide and Seek</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22121.mp3?mediaType=feedmp3</link>
<description>
"Humanized Mouse Models for Studies On HIV Latency, Reservoirs, and Eradication Strategies" by J. Victor Garcia-Martinez of University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22121.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22121.mp3</guid>	
 
<itunes:summary>Symposium: Toward a Cure: A Challenging Game of Hide and Seek

"Humanized Mouse Models for Studies On HIV Latency, Reservoirs, and Eradication Strategies" by J. Victor Garcia-Martinez of University of North Carolina at Chapel Hill, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: HCV and Beyond</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22125.mp3?mediaType=feedmp3</link>
<description>
"HEV: State of the Art" by Kenneth E. Sherman of University of Cincinnati College of Medicine, Cinncinnati, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22125.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22125.mp3</guid>	
 
<itunes:summary>Symposium: HCV and Beyond

"HEV: State of the Art" by Kenneth E. Sherman of University of Cincinnati College of Medicine, Cinncinnati, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: HCV and Beyond</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22126.mp3?mediaType=feedmp3</link>
<description>
"HBV Eradication: Similarities To and Differences From HIV" by Shyam Kottilil of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22126.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22126.mp3</guid>	
 
<itunes:summary>Symposium: HCV and Beyond

"HBV Eradication: Similarities To and Differences From HIV" by Shyam Kottilil of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: HCV and Beyond</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22127.mp3?mediaType=feedmp3</link>
<description>
"Humoral Immunity and the Innate Response To HCV" by Andrea L. Cox of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22127.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22127.mp3</guid>	
 
<itunes:summary>Symposium: HCV and Beyond

"Humoral Immunity and the Innate Response To HCV" by Andrea L. Cox of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: HCV and Beyond</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22128.mp3?mediaType=feedmp3</link>
<description>
"Interferon Alfa-Free Treatment of HCV" by Jean-Michel Pawlotsky of Henri Mondor Hospital, University of Paris-Est, Créteil, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22128.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22128.mp3</guid>	
 
<itunes:summary>Symposium: HCV and Beyond

"Interferon Alfa-Free Treatment of HCV" by Jean-Michel Pawlotsky of Henri Mondor Hospital, University of Paris-Est, Créteil, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: PrEP: Use It or Lose It</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22132.mp3?mediaType=feedmp3</link>
<description>
"HIV Pre-Exposure Prophylaxis: Clinical Pharmacology Insights" by Craig W. Hendrix of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22132.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22132.mp3</guid>	
 
<itunes:summary>Symposium: PrEP: Use It or Lose It

"HIV Pre-Exposure Prophylaxis: Clinical Pharmacology Insights" by Craig W. Hendrix of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: PrEP: Use It or Lose It</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22133.mp3?mediaType=feedmp3</link>
<description>
"Notes From the Field: Implementing PrEP in Resource Constrained Settings" by Nelly R. Mugo of Kenya Medical Research Institute, Nairobi, Kenya
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22133.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22133.mp3</guid>	
 
<itunes:summary>Symposium: PrEP: Use It or Lose It

"Notes From the Field: Implementing PrEP in Resource Constrained Settings" by Nelly R. Mugo of Kenya Medical Research Institute, Nairobi, Kenya

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: PrEP: Use It or Lose It</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22134.mp3?mediaType=feedmp3</link>
<description>
"A Community Perspective On PrEP" by Christopher Balthazar and London Dorris of Stroger Hospital of Cook County, Chicago, IL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22134.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22134.mp3</guid>	
 
<itunes:summary>Symposium: PrEP: Use It or Lose It

"A Community Perspective On PrEP" by Christopher Balthazar and London Dorris of Stroger Hospital of Cook County, Chicago, IL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: PrEP: Use It or Lose It</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22135.mp3?mediaType=feedmp3</link>
<description>
"Choosing Populations for Maximal Impact" by David V. Glidden of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22135.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22135.mp3</guid>	
 
<itunes:summary>Symposium: PrEP: Use It or Lose It

"Choosing Populations for Maximal Impact" by David V. Glidden of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: B-Cell Responses To HIV Infection: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22137.mp3?mediaType=feedmp3</link>
<description>
"B-Cell Responses To HIV Infection: Challenges and Opportunities" by Susan L. Moir of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22137.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22137.mp3</guid>	
 
<itunes:summary>Plenary: B-Cell Responses To HIV Infection: Challenges and Opportunities

"B-Cell Responses To HIV Infection: Challenges and Opportunities" by Susan L. Moir of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: NeuroHIV in 2014: Beyond Dementia</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22138.mp3?mediaType=feedmp3</link>
<description>
"NeuroHIV in 2014: Beyond Dementia" by Serena S. Spudich of Yale University, New Haven, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22138.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22138.mp3</guid>	
 
<itunes:summary>Plenary: NeuroHIV in 2014: Beyond Dementia

"NeuroHIV in 2014: Beyond Dementia" by Serena S. Spudich of Yale University, New Haven, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22141.mp3?mediaType=feedmp3</link>
<description>
"A 15-Year Review of Maternal Deaths in a Background of Changing HIV Management Guidelines" by Coceka N. Mnyani of Anova Health Institute, Johannesburg, South Africa and University of the Witwatersrand, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22141.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22141.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"A 15-Year Review of Maternal Deaths in a Background of Changing HIV Management Guidelines" by Coceka N. Mnyani of Anova Health Institute, Johannesburg, South Africa and University of the Witwatersrand, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22142.mp3?mediaType=feedmp3</link>
<description>
"Incidence and Cofactors of Acute HIV During Pregnancy and Postpartum" by John Kinuthia of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22142.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22142.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Incidence and Cofactors of Acute HIV During Pregnancy and Postpartum" by John Kinuthia of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22143.mp3?mediaType=feedmp3</link>
<description>
"Efficacy and Safety of LPV/r Versus EFV in HIV+ Pregnant and Breast-Feeding Ugandan Women" by Deborah Cohan of OBGYN, University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22143.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22143.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Efficacy and Safety of LPV/r Versus EFV in HIV+ Pregnant and Breast-Feeding Ugandan Women" by Deborah Cohan of OBGYN, University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22144.mp3?mediaType=feedmp3</link>
<description>
"Infant Lopinavir/r Versus 3TC To Prevent Postnatal HIV-1 Transmission: The ANRS 12174 Trial" by Chipepo Kankasa of Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22144.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22144.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Infant Lopinavir/r Versus 3TC To Prevent Postnatal HIV-1 Transmission: The ANRS 12174 Trial" by Chipepo Kankasa of Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22145.mp3?mediaType=feedmp3</link>
<description>
"Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate" by George K. Siberry of NICHD, Maternal and Pediatric Infectious Disease Branch, NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22145.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22145.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate" by George K. Siberry of NICHD, Maternal and Pediatric Infectious Disease Branch, NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22146.mp3?mediaType=feedmp3</link>
<description>
"Virologic Control by 1 Year of Age Significantly Reduces HIV-1 Reservoirs in Perinatal Infection" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22146.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22146.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Virologic Control by 1 Year of Age Significantly Reduces HIV-1 Reservoirs in Perinatal Infection" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22147.mp3?mediaType=feedmp3</link>
<description>
"Virologic Efficacy of Efavirenz Maintenance Therapy in Nevirapine Prophylaxis-ExposedChildren" by Ashraf Coovadia of University of the Witwatersrand, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22147.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22147.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Virologic Efficacy of Efavirenz Maintenance Therapy in Nevirapine Prophylaxis-ExposedChildren" by Ashraf Coovadia of University of the Witwatersrand, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22148.mp3?mediaType=feedmp3</link>
<description>
"Final Results of Koncert: A Randomized Noninferiority Trial of QD Vs BD LPV/r Dosing in Children" by Hermione Lyall of Imperial College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22148.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22148.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Final Results of Koncert: A Randomized Noninferiority Trial of QD Vs BD LPV/r Dosing in Children" by Hermione Lyall of Imperial College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22149.mp3?mediaType=feedmp3</link>
<description>
"Very Early Combination Antiretroviral Therapy in Perinatal HIV Infection: Two Case Studies" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22149.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22149.mp3</guid>	
 
<itunes:summary>Oral Abstract: Critical Issues in MTCT: Maternal Health, and HIV Treatment in Children

"Very Early Combination Antiretroviral Therapy in Perinatal HIV Infection: Two Case Studies" by Deborah Persaud of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22153.mp3?mediaType=feedmp3</link>
<description>
"Pyroptosis Drives Both CD4 T Cell Death and Chronic Inflammation in HIV-Infected Lymphoid Tissues" by Gilad Doitsh of Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22153.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22153.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Pyroptosis Drives Both CD4 T Cell Death and Chronic Inflammation in HIV-Infected Lymphoid Tissues" by Gilad Doitsh of Gladstone Institute of Virology and Immunology, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22154.mp3?mediaType=feedmp3</link>
<description>
"Early ART Initiation Prevents Disruption of the Mucosal Barrier and Subsequent T-Cell Activation" by Alexandra Schuetz of Retrovirology, USAMC-AFRIMS, Bangkok, Thailand
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22154.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22154.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Early ART Initiation Prevents Disruption of the Mucosal Barrier and Subsequent T-Cell Activation" by Alexandra Schuetz of Retrovirology, USAMC-AFRIMS, Bangkok, Thailand

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22155.mp3?mediaType=feedmp3</link>
<description>
"Characterizing the IFNα Resistance of Transmitted Founder HIV-1" by Shilpa S. Iyer of Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22155.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22155.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Characterizing the IFNα Resistance of Transmitted Founder HIV-1" by Shilpa S. Iyer of Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22156.mp3?mediaType=feedmp3</link>
<description>
"Identification of IFI16 as HIV Restriction Factor" by Amalio Telenti of University of Lausanne, Lausanne, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22156.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22156.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Identification of IFI16 as HIV Restriction Factor" by Amalio Telenti of University of Lausanne, Lausanne, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22157.mp3?mediaType=feedmp3</link>
<description>
"Central Memory and Effector Memory CD4 T Cells From HIV Controllers Harbor Distinct HIV Strains" by Eli Boritz of Human Immunology Section, Vaccine Research Center, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22157.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22157.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Central Memory and Effector Memory CD4 T Cells From HIV Controllers Harbor Distinct HIV Strains" by Eli Boritz of Human Immunology Section, Vaccine Research Center, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22158.mp3?mediaType=feedmp3</link>
<description>
"Accelerated Viral Load Increase and CD4 Decline in HIV-1 Superinfected Women" by Keshet Ronen of Fred Hutchinson Cancer Research Center, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22158.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22158.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Accelerated Viral Load Increase and CD4 Decline in HIV-1 Superinfected Women" by Keshet Ronen of Fred Hutchinson Cancer Research Center, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22159.mp3?mediaType=feedmp3</link>
<description>
"Selection for Active SAMHD1 Antagonism in Natural Infections of SIVagm" by Chelsea Spragg of Molecular and Cellular Biology, University of Washington, Seattle, WA, United States and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22159.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22159.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Selection for Active SAMHD1 Antagonism in Natural Infections of SIVagm" by Chelsea Spragg of Molecular and Cellular Biology, University of Washington, Seattle, WA, United States and Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: HIV/SIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22160.mp3?mediaType=feedmp3</link>
<description>
"Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques" by Alexandra M. Ortiz of LMM, NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22160.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22160.mp3</guid>	
 
<itunes:summary>Oral Abstract: HIV/SIV Pathogenesis

"Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques" by Alexandra M. Ortiz of LMM, NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22164.mp3?mediaType=feedmp3</link>
<description>
"First-Line RAL + DRV/r Is Non-Inferior To TDF/FTC + DRV/r: The NEAT001/ANRS143 Randomised Trial" by François Raffi of University Hospital, Nantes, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22164.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22164.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"First-Line RAL + DRV/r Is Non-Inferior To TDF/FTC + DRV/r: The NEAT001/ANRS143 Randomised Trial" by François Raffi of University Hospital, Nantes, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22165.mp3?mediaType=feedmp3</link>
<description>
"Efficacy and Tolerability of Atazanavir, Raltegravir, or Darunavir With FTC/Tenofovir: ACTG 5257" by Raphael J. Landovitz of Center for Clinical AIDS Research &amp; Education, University of California Los Angeles, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22165.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22165.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Efficacy and Tolerability of Atazanavir, Raltegravir, or Darunavir With FTC/Tenofovir: ACTG 5257" by Raphael J. Landovitz of Center for Clinical AIDS Research &amp; Education, University of California Los Angeles, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22166.mp3?mediaType=feedmp3</link>
<description>
"Attachment Inhibitor Prodrug BMS-663068 in ARV-Experienced Subjects: Week 24 Analysis" by Jacob Lalezari of Quest Clinical Research, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22166.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22166.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Attachment Inhibitor Prodrug BMS-663068 in ARV-Experienced Subjects: Week 24 Analysis" by Jacob Lalezari of Quest Clinical Research, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22167.mp3?mediaType=feedmp3</link>
<description>
"Sensitive Screening Reveals Widespread Underestimation of Transmitted HIV Drug Resistance" by Jeffrey A. Johnson of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22167.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22167.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Sensitive Screening Reveals Widespread Underestimation of Transmitted HIV Drug Resistance" by Jeffrey A. Johnson of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22168.mp3?mediaType=feedmp3</link>
<description>
"Transmitted HIV-1 Drug Resistance Between Partner-Pairs" by Lisa M. Frenkel of University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22168.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22168.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Transmitted HIV-1 Drug Resistance Between Partner-Pairs" by Lisa M. Frenkel of University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22169.mp3?mediaType=feedmp3</link>
<description>
"Silent Mutations in HIV-1 Subtype B Reverse Transcriptase Selected by ART Restore Viral Fitness" by Sushama Telwatte of Centre for Biomedical Research, Burnet Institute, Melbourne, Australia and Department of Microbiology, Monash University, Melbourne, Australia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22169.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22169.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Silent Mutations in HIV-1 Subtype B Reverse Transcriptase Selected by ART Restore Viral Fitness" by Sushama Telwatte of Centre for Biomedical Research, Burnet Institute, Melbourne, Australia and Department of Microbiology, Monash University, Melbourne, Australia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22170.mp3?mediaType=feedmp3</link>
<description>
"Reduced In Vivo Replicative Capacity of Drug-Resistant SHIV During Acute Infection" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22170.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22170.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Reduced In Vivo Replicative Capacity of Drug-Resistant SHIV During Acute Infection" by J. Gerardo Garcia-Lerma of Division of HIV/AIDS Prevention, CDC, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22171.mp3?mediaType=feedmp3</link>
<description>
"744 and Rilpivirine as Two-Drug Oral Maintenance Therapy: LAI116482 (LATTE) Week 48 Results" by David Margolis of GSK, RTP, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22171.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22171.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"744 and Rilpivirine as Two-Drug Oral Maintenance Therapy: LAI116482 (LATTE) Week 48 Results" by David Margolis of GSK, RTP, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22172.mp3?mediaType=feedmp3</link>
<description>
"Safety and Antiviral Effect of MK-1439, A Novel NNRTI (+FTC/TDF) in ART-Naive HIV-Infected Patients" by Javier O. Morales-Ramirez of Clinical Research Puerto Rico, San Juan, Puerto Rico
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22172.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22172.mp3</guid>	
 
<itunes:summary>Oral Abstract: Randomized Controlled Trials and Antiretroviral Resistance

"Safety and Antiviral Effect of MK-1439, A Novel NNRTI (+FTC/TDF) in ART-Naive HIV-Infected Patients" by Javier O. Morales-Ramirez of Clinical Research Puerto Rico, San Juan, Puerto Rico

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: TB and Other Coinfections</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22176.mp3?mediaType=feedmp3</link>
<description>
"A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment" by Susan E. Dorman of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22176.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22176.mp3</guid>	
 
<itunes:summary>Oral Abstract: TB and Other Coinfections

"A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment" by Susan E. Dorman of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: TB and Other Coinfections</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22177.mp3?mediaType=feedmp3</link>
<description>
"Tuberculosis Infection in Early Childhood in Uganda and the Influence of HIV Exposure" by Carina Marquez of University of California, San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22177.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22177.mp3</guid>	
 
<itunes:summary>Oral Abstract: TB and Other Coinfections

"Tuberculosis Infection in Early Childhood in Uganda and the Influence of HIV Exposure" by Carina Marquez of University of California, San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: TB and Other Coinfections</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22178.mp3?mediaType=feedmp3</link>
<description>
"Effect of Xpert MTB/RIF On Early Mortality in Adults With Suspected TB: A Pragmatic Randomized Trial" by Gavin Churchyard of Aurum Institute, Houghton, South Africa
"Xpert as the First-Line TB Test in South Africa: Yield, Initial Loss To Follow-Up, Proportion Treated" by Katherine L. Fielding of London School of Hygiene &amp; Tropical Medicine, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22178.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22178.mp3</guid>	
 
<itunes:summary>Oral Abstract: TB and Other Coinfections

"Effect of Xpert MTB/RIF On Early Mortality in Adults With Suspected TB: A Pragmatic Randomized Trial" by Gavin Churchyard of Aurum Institute, Houghton, South Africa
"Xpert as the First-Line TB Test in South Africa: Yield, Initial Loss To Follow-Up, Proportion Treated" by Katherine L. Fielding of London School of Hygiene &amp; Tropical Medicine, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: TB and Other Coinfections</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22180.mp3?mediaType=feedmp3</link>
<description>
"14 Day EBA Study of PA-824, Bedaquiline, Pyrazinamide and Clofazimine in Smear-Positive TB Patients" by Andreas Diacon of Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22180.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22180.mp3</guid>	
 
<itunes:summary>Oral Abstract: TB and Other Coinfections

"14 Day EBA Study of PA-824, Bedaquiline, Pyrazinamide and Clofazimine in Smear-Positive TB Patients" by Andreas Diacon of Department of Medical Biochemistry, Stellenbosch University, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: TB and Other Coinfections</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22181.mp3?mediaType=feedmp3</link>
<description>
"CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial" by Christina S. Polyak of Military HIV Research Program, Walter Reed Army Institute of Research, University of Washington, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22181.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22181.mp3</guid>	
 
<itunes:summary>Oral Abstract: TB and Other Coinfections

"CTX Prophylaxis Discontinuation Among ART-Treated Adults: A Randomized Non-Inferiority Trial" by Christina S. Polyak of Military HIV Research Program, Walter Reed Army Institute of Research, University of Washington, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22183.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Susan Cu-Uvin of Brown University, Providence, RI, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22183.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22183.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Discussion Leader" by Susan Cu-Uvin of Brown University, Providence, RI, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22184.mp3?mediaType=feedmp3</link>
<description>
"Depot-Medroxyprogesterone Acetate Does Not Increase Genital SHIV Shedding in Macaques" by Jessica Radzio of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22184.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22184.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Depot-Medroxyprogesterone Acetate Does Not Increase Genital SHIV Shedding in Macaques" by Jessica Radzio of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22185.mp3?mediaType=feedmp3</link>
<description>
"Hormonal Contraceptives Increase Innate Immune Effector Molecules in Cervicovaginal Secretions" by Alison Roxby of Department of Global Health, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22185.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22185.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Hormonal Contraceptives Increase Innate Immune Effector Molecules in Cervicovaginal Secretions" by Alison Roxby of Department of Global Health, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22186.mp3?mediaType=feedmp3</link>
<description>
"Injectable Contraception and HIV Acquisition in the VOICE Study (MTN-003)" by Lisa M. Noguchi of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States and Microbicide Trials Network, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22186.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22186.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Injectable Contraception and HIV Acquisition in the VOICE Study (MTN-003)" by Lisa M. Noguchi of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States and Microbicide Trials Network, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22187.mp3?mediaType=feedmp3</link>
<description>
"Dysregulation of Estradiol Signaling Contributes To Mucosal Barrier Dysfunction HIV+ Women" by Sumathi Sankaran-Walters of Medical Microbiology and Immunology, University of CA, Davis, Davis, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22187.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22187.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Dysregulation of Estradiol Signaling Contributes To Mucosal Barrier Dysfunction HIV+ Women" by Sumathi Sankaran-Walters of Medical Microbiology and Immunology, University of CA, Davis, Davis, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22188.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22188.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22188.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22189.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Marion G. Peters of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22189.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22189.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Discussion Leader" by Marion G. Peters of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22190.mp3?mediaType=feedmp3</link>
<description>
"Telaprevir in Treatment-Experienced HIV-HCV G1 Coinfected Patients (ANRS HC26 TelapreVIH)" by Laurent Cotte of Infectious Diseases, Hospices Civils de Lyon, Lyon, France and U1052, INSERM, Lyon, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22190.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22190.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Telaprevir in Treatment-Experienced HIV-HCV G1 Coinfected Patients (ANRS HC26 TelapreVIH)" by Laurent Cotte of Infectious Diseases, Hospices Civils de Lyon, Lyon, France and U1052, INSERM, Lyon, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22191.mp3?mediaType=feedmp3</link>
<description>
"Boceprevir/Telaprevir-Based Therapy in HIV-Infection: Interim Analysis of a Multicenter Cohort" by Karin Neukam of Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain and University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22191.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22191.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Boceprevir/Telaprevir-Based Therapy in HIV-Infection: Interim Analysis of a Multicenter Cohort" by Karin Neukam of Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain and University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22192.mp3?mediaType=feedmp3</link>
<description>
"Protease Inhibitors To Treat Hepatitis C in the Swiss HIV Cohort Study: High Efficacy But Low Uptake" by Sebastian Haubitz of Division of Infectious Diseases, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22192.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22192.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Protease Inhibitors To Treat Hepatitis C in the Swiss HIV Cohort Study: High Efficacy But Low Uptake" by Sebastian Haubitz of Division of Infectious Diseases, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22193.mp3?mediaType=feedmp3</link>
<description>
"Slow HCV-RNA Decay and Early Resistance Predict the Risk of Failure To TVR/BOC Treatment" by Francesca Ceccherini-Silberstein of Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22193.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22193.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Slow HCV-RNA Decay and Early Resistance Predict the Risk of Failure To TVR/BOC Treatment" by Francesca Ceccherini-Silberstein of Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22194.mp3?mediaType=feedmp3</link>
<description>
"Favorable Adverse Event Profile of Sofosbuvir/Ribavirin Versus Standard of Care for Hepatitis C" by Kerry Townsend of LIR, NIAID, NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22194.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22194.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Favorable Adverse Event Profile of Sofosbuvir/Ribavirin Versus Standard of Care for Hepatitis C" by Kerry Townsend of LIR, NIAID, NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22195.mp3?mediaType=feedmp3</link>
<description>
"Sustained Virologic Response and the Risk of Liver Decompensation in HCV and HIV/HCV Patients" by Temitope O. Olufade of US Outcomes Research, Merck Sharpe &amp; Dohme, North Wales, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22195.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22195.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Sustained Virologic Response and the Risk of Liver Decompensation in HCV and HIV/HCV Patients" by Temitope O. Olufade of US Outcomes Research, Merck Sharpe &amp; Dohme, North Wales, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22196.mp3?mediaType=feedmp3</link>
<description>
"Predicting Risk of ESLD in HIV/HCV Patients for Individualized HCV Therapy Decisions" by Vincent Lo Re of University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22196.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22196.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Predicting Risk of ESLD in HIV/HCV Patients for Individualized HCV Therapy Decisions" by Vincent Lo Re of University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22197.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22197.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22197.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22198.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Kevin E. Yarasheski of Washington University School of Medicine, St Louis, MO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22198.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22198.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Discussion Leader" by Kevin E. Yarasheski of Washington University School of Medicine, St Louis, MO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22199.mp3?mediaType=feedmp3</link>
<description>
"Geriatric Syndromes Are Common Among Older HIV-Infected Adults" by Meredith Greene of Medicine-Geriatrics, University of California San Francisco, San Francisco, CA, United States and San Francisco VA Medical Center, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22199.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22199.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Geriatric Syndromes Are Common Among Older HIV-Infected Adults" by Meredith Greene of Medicine-Geriatrics, University of California San Francisco, San Francisco, CA, United States and San Francisco VA Medical Center, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22200.mp3?mediaType=feedmp3</link>
<description>
"Physical Function Impairment On Quality of Life Among Persons Aging With HIV Infection" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22200.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22200.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Physical Function Impairment On Quality of Life Among Persons Aging With HIV Infection" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22201.mp3?mediaType=feedmp3</link>
<description>
"Cell-Mediated CMV Responses in HIV-Infected Persons With Impaired Physical Function" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22201.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22201.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Cell-Mediated CMV Responses in HIV-Infected Persons With Impaired Physical Function" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22202.mp3?mediaType=feedmp3</link>
<description>
"Frailty, Inflammation and Mortality Among Aging HIV-Infected and At-Risk Injection Drug Users" by Damani A. Piggott of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22202.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22202.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Frailty, Inflammation and Mortality Among Aging HIV-Infected and At-Risk Injection Drug Users" by Damani A. Piggott of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22203.mp3?mediaType=feedmp3</link>
<description>
"Brisk Walking Improves Inflammatory Markers in cART-Treated Patients" by Valeria Longo of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22203.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22203.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Brisk Walking Improves Inflammatory Markers in cART-Treated Patients" by Valeria Longo of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22204.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22204.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22204.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22205.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Stephen Taylor of Birmingham Heartlands Hospital, Birmingham, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22205.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22205.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Discussion Leader" by Stephen Taylor of Birmingham Heartlands Hospital, Birmingham, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22206.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetics of Raltegravir 400 vs 800 mg BID With Intermittent Rifampicin Dosed Thrice Weekly" by Saye H. Khoo of University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22206.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22206.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Pharmacokinetics of Raltegravir 400 vs 800 mg BID With Intermittent Rifampicin Dosed Thrice Weekly" by Saye H. Khoo of University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22207.mp3?mediaType=feedmp3</link>
<description>
"Relationship Between Efavirenz Trough &amp; CYP2B6 Genotypes With Rifampin-Based TB Therapy in STRIDE" by Anne Luetkemeyer of HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22207.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22207.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Relationship Between Efavirenz Trough &amp; CYP2B6 Genotypes With Rifampin-Based TB Therapy in STRIDE" by Anne Luetkemeyer of HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22208.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetics of Faldaprevir and Antiretrovirals in Patients With HIV/HCV Coinfection" by Jürgen K. K. Rockstroh of Department of Medicine I, University of Bonn, Bonn, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22208.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22208.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Pharmacokinetics of Faldaprevir and Antiretrovirals in Patients With HIV/HCV Coinfection" by Jürgen K. K. Rockstroh of Department of Medicine I, University of Bonn, Bonn, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22209.mp3?mediaType=feedmp3</link>
<description>
"Relative Genetic Contribution To the Pharmacokinetics of Commonly Prescribed Antiretrovirals" by Marco S. Siccardi of Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22209.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22209.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Relative Genetic Contribution To the Pharmacokinetics of Commonly Prescribed Antiretrovirals" by Marco S. Siccardi of Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22210.mp3?mediaType=feedmp3</link>
<description>
"Leveraging Genomics in HIV Treatment Decisions" by Paul J. McLaren of The Swiss HIV Cohort, Lausanne, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22210.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22210.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Leveraging Genomics in HIV Treatment Decisions" by Paul J. McLaren of The Swiss HIV Cohort, Lausanne, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22211.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22211.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22211.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22212.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22212.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22212.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Discussion Leader" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22213.mp3?mediaType=feedmp3</link>
<description>
"HIV Transmission in the United States: The Roles of Risk Group, Race/Ethnicity, and Geography" by Alexandra M. Oster of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22213.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22213.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"HIV Transmission in the United States: The Roles of Risk Group, Race/Ethnicity, and Geography" by Alexandra M. Oster of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22214.mp3?mediaType=feedmp3</link>
<description>
"Ongoing HIV-1 Subtype B Transmission Networks in the Netherlands" by Daniela Bezemer of Research, HIV Monitoring Foundation, Amsterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22214.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22214.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Ongoing HIV-1 Subtype B Transmission Networks in the Netherlands" by Daniela Bezemer of Research, HIV Monitoring Foundation, Amsterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22215.mp3?mediaType=feedmp3</link>
<description>
"Using HIV Networks To Inform Real Time Prevention Interventions" by Susan J. Little of Medicine, University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22215.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22215.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Using HIV Networks To Inform Real Time Prevention Interventions" by Susan J. Little of Medicine, University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22216.mp3?mediaType=feedmp3</link>
<description>
"Large MSM Group and Local Heterosexual Transmission Are Major Concerns in the HIV Epidemic in Japan" by Teiichiro Shiino of Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22216.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22216.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Large MSM Group and Local Heterosexual Transmission Are Major Concerns in the HIV Epidemic in Japan" by Teiichiro Shiino of Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22217.mp3?mediaType=feedmp3</link>
<description>
"Transmission Networks of HIV-1 Subtype B, CRF01_AE and CRF51_01B Among MSM in Singapore" by Kim Tien Ng of Centre of Excellence for Research in AIDS (CERiA), Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22217.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22217.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Transmission Networks of HIV-1 Subtype B, CRF01_AE and CRF51_01B Among MSM in Singapore" by Kim Tien Ng of Centre of Excellence for Research in AIDS (CERiA), Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22218.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Phylodynamics and Phylogeography Among High-Risk and General Populations in Uganda" by Gonzalo Yebra of Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22218.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22218.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"HIV-1 Phylodynamics and Phylogeography Among High-Risk and General Populations in Uganda" by Gonzalo Yebra of Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22219.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22219.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22219.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22220.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Peter W. Hunt of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22220.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22220.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Discussion Leader" by Peter W. Hunt of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22221.mp3?mediaType=feedmp3</link>
<description>
"Rapid Gut-Homing of Plasmacytoid Dendritic Cells During Acute SIV Infection" by R. Keith Reeves of NEPRC, Harvard Medical School, Southborough, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22221.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22221.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Rapid Gut-Homing of Plasmacytoid Dendritic Cells During Acute SIV Infection" by R. Keith Reeves of NEPRC, Harvard Medical School, Southborough, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22222.mp3?mediaType=feedmp3</link>
<description>
"CCR6+ and CD161+ CD4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques" by Colleen S. McGary of Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22222.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22222.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"CCR6+ and CD161+ CD4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques" by Colleen S. McGary of Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22223.mp3?mediaType=feedmp3</link>
<description>
"Decreased Diversity of Gut Microbiota Is Associated With Immune Status During HIV-1 Infection" by Babilonia Barqasho of Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22223.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22223.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Decreased Diversity of Gut Microbiota Is Associated With Immune Status During HIV-1 Infection" by Babilonia Barqasho of Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22224.mp3?mediaType=feedmp3</link>
<description>
"Dysbiotic Bacteria Translocate in Progressive SIV Infection" by Zachary Klase of Laboratory of Molecular Microbiology, NIAID/NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22224.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22224.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Dysbiotic Bacteria Translocate in Progressive SIV Infection" by Zachary Klase of Laboratory of Molecular Microbiology, NIAID/NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22225.mp3?mediaType=feedmp3</link>
<description>
"Breaches in Colonic Claudin-4 Expression Correlate With T-Cell Activation in HIV-1 Infection" by Louise Greathead of Imperial College, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22225.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22225.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Breaches in Colonic Claudin-4 Expression Correlate With T-Cell Activation in HIV-1 Infection" by Louise Greathead of Imperial College, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22226.mp3?mediaType=feedmp3</link>
<description>
"Increased Immune Activation After Gut Permeabilization in SIV-Infected African Green Monkeys" by Jan Kristoff of Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22226.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22226.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Increased Immune Activation After Gut Permeabilization in SIV-Infected African Green Monkeys" by Jan Kristoff of Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22227.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22227.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22227.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22230.mp3?mediaType=feedmp3</link>
<description>
"HIV and Elevated Cancer-Specific Mortality Following Cancer Diagnosis in the United States" by Anna E. Coghill of Division of Cancer Epidemiology and Genetics, National Cancer Institute, Washington, DC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22230.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22230.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"HIV and Elevated Cancer-Specific Mortality Following Cancer Diagnosis in the United States" by Anna E. Coghill of Division of Cancer Epidemiology and Genetics, National Cancer Institute, Washington, DC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22231.mp3?mediaType=feedmp3</link>
<description>
"Impact of Kaposi Sarcoma On Survival in HIV-Infected African Adults On Antiretroviral Therapy" by Stephen B. Asiimwe of Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States and Department of Internal Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22231.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22231.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Impact of Kaposi Sarcoma On Survival in HIV-Infected African Adults On Antiretroviral Therapy" by Stephen B. Asiimwe of Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States and Department of Internal Medicine, Mbarara Regional Referral Hospital, Mbarara, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22232.mp3?mediaType=feedmp3</link>
<description>
"Prospective Characterization of Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome" by Mark N. Polizzotto of HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22232.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22232.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Prospective Characterization of Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome" by Mark N. Polizzotto of HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22233.mp3?mediaType=feedmp3</link>
<description>
"Quadrivalent HPV Vaccine Demonstrates Immune Memory in HIV-1-Infected Men" by Timothy Wilkin of Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22233.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22233.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Quadrivalent HPV Vaccine Demonstrates Immune Memory in HIV-1-Infected Men" by Timothy Wilkin of Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22234.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Infection Alters Intestinal Expression of Antiretroviral Drug Transporters and Enzymes" by Reina Bendayan of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22234.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22234.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"HIV-1 Infection Alters Intestinal Expression of Antiretroviral Drug Transporters and Enzymes" by Reina Bendayan of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22235.mp3?mediaType=feedmp3</link>
<description>
"Tenofovir-Emtricitabine Directly Observed Dosing: 100% Adherence Concentrations (HPTN 066)" by Craig W. Hendrix of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22235.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22235.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Tenofovir-Emtricitabine Directly Observed Dosing: 100% Adherence Concentrations (HPTN 066)" by Craig W. Hendrix of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22236.mp3?mediaType=feedmp3</link>
<description>
"Efavirenz Pharmacokinetics in HIV+ Persons Receiving Rifapentine and Isoniazid for TB Prevention" by Anthony T. Podany of College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22236.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22236.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Efavirenz Pharmacokinetics in HIV+ Persons Receiving Rifapentine and Isoniazid for TB Prevention" by Anthony T. Podany of College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Malignancies and Pharmacology</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22237.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetic Variability in TB Therapy: Associations With HIV and Effect On Outcome" by Derek J. Sloan of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22237.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22237.mp3</guid>	
 
<itunes:summary>Oral Abstract: Malignancies and Pharmacology

"Pharmacokinetic Variability in TB Therapy: Associations With HIV and Effect On Outcome" by Derek J. Sloan of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22241.mp3?mediaType=feedmp3</link>
<description>
"The Genetics and Pathogenesis of MDR and XDR TB Drug Resistance" by Megan B. Murray of Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22241.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22241.mp3</guid>	
 
<itunes:summary>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control

"The Genetics and Pathogenesis of MDR and XDR TB Drug Resistance" by Megan B. Murray of Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22242.mp3?mediaType=feedmp3</link>
<description>
"Is Latent TB Infection Really Latent?" by Petros C. Karakousis of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22242.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22242.mp3</guid>	
 
<itunes:summary>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control

"Is Latent TB Infection Really Latent?" by Petros C. Karakousis of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22243.mp3?mediaType=feedmp3</link>
<description>
"Quantifying TB Treatment Response Using PET/CT" by Clifton E. Barry III of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22243.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22243.mp3</guid>	
 
<itunes:summary>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control

"Quantifying TB Treatment Response Using PET/CT" by Clifton E. Barry III of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22244.mp3?mediaType=feedmp3</link>
<description>
"Population-Level Control of HIV-Related TB" by Peter Godfrey-Faussett of Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22244.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22244.mp3</guid>	
 
<itunes:summary>Symposium: TB: Looking to the Future: Resistance, Persistence, Monitoring, and Control

"Population-Level Control of HIV-Related TB" by Peter Godfrey-Faussett of Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Visualizing the Virus</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22246.mp3?mediaType=feedmp3</link>
<description>
"Convener" by Hans-Georg Kräusslich of University of Heidelberg, Heidelberg, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22246.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22246.mp3</guid>	
 
<itunes:summary>Symposium: Visualizing the Virus

"Convener" by Hans-Georg Kräusslich of University of Heidelberg, Heidelberg, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Visualizing the Virus</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22248.mp3?mediaType=feedmp3</link>
<description>
"An Ingenious Cloak for Subterfuge: The HIV Capsid Structure" by Angela M. Gronenborn of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22248.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22248.mp3</guid>	
 
<itunes:summary>Symposium: Visualizing the Virus

"An Ingenious Cloak for Subterfuge: The HIV Capsid Structure" by Angela M. Gronenborn of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Visualizing the Virus</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22249.mp3?mediaType=feedmp3</link>
<description>
"Structure of a Soluble, Cleaved HIV-1 Env Trimer and Its Interaction With Broadly Neutralizing Antibodies" by Ian A. Wilson of The Scripps Research Institute, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22249.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22249.mp3</guid>	
 
<itunes:summary>Symposium: Visualizing the Virus

"Structure of a Soluble, Cleaved HIV-1 Env Trimer and Its Interaction With Broadly Neutralizing Antibodies" by Ian A. Wilson of The Scripps Research Institute, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Visualizing the Virus</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22250.mp3?mediaType=feedmp3</link>
<description>
"Imaging the Molecular Dance of Single HIV-1 Env Molecules" by Walter H. Mothes of Yale University, New Haven, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22250.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22250.mp3</guid>	
 
<itunes:summary>Symposium: Visualizing the Virus

"Imaging the Molecular Dance of Single HIV-1 Env Molecules" by Walter H. Mothes of Yale University, New Haven, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Visualizing the Virus</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22251.mp3?mediaType=feedmp3</link>
<description>
"Kill HIV by Starvation: SAMHD1 as a Potent Viral Restriction Factor and a Master Regulator of Cellular dNTP Metabolism" by Yong Xiong of Yale University, New Haven, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22251.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22251.mp3</guid>	
 
<itunes:summary>Symposium: Visualizing the Virus

"Kill HIV by Starvation: SAMHD1 as a Potent Viral Restriction Factor and a Master Regulator of Cellular dNTP Metabolism" by Yong Xiong of Yale University, New Haven, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Know Your Epidemic: From Data to Action</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22255.mp3?mediaType=feedmp3</link>
<description>
"Population Surveys: What Do They Show?" by Peter D. Ghys of Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22255.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22255.mp3</guid>	
 
<itunes:summary>Symposium: Know Your Epidemic: From Data to Action

"Population Surveys: What Do They Show?" by Peter D. Ghys of Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Know Your Epidemic: From Data to Action</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22256.mp3?mediaType=feedmp3</link>
<description>
"MSM in the UK: Prevention Effects of ART in Perspective" by Andrew Phillips of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22256.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22256.mp3</guid>	
 
<itunes:summary>Symposium: Know Your Epidemic: From Data to Action

"MSM in the UK: Prevention Effects of ART in Perspective" by Andrew Phillips of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Know Your Epidemic: From Data to Action</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22257.mp3?mediaType=feedmp3</link>
<description>
"Understanding Networks of HIV Transmission" by Stéphane Helleringer of Columbia University, New York City, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22257.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22257.mp3</guid>	
 
<itunes:summary>Symposium: Know Your Epidemic: From Data to Action

"Understanding Networks of HIV Transmission" by Stéphane Helleringer of Columbia University, New York City, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Know Your Epidemic: From Data to Action</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22258.mp3?mediaType=feedmp3</link>
<description>
"From Evidence To Policy: Experience From Swaziland" by Velephi J. Okello of Swaziland National AIDS Programme, Mbabane, Swaziland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22258.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22258.mp3</guid>	
 
<itunes:summary>Symposium: Know Your Epidemic: From Data to Action

"From Evidence To Policy: Experience From Swaziland" by Velephi J. Okello of Swaziland National AIDS Programme, Mbabane, Swaziland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: HIV-1 Infection and Type-1 Interferon</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22260.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Infection and Type-1 Interferon" by Michael H. Malim of King’s College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22260.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22260.mp3</guid>	
 
<itunes:summary>Plenary: HIV-1 Infection and Type-1 Interferon

"HIV-1 Infection and Type-1 Interferon" by Michael H. Malim of King’s College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 
	

 
 
 

 


















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Plenary: PEPFAR/Global Fund at 10 years: Past, Present, and Future</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22261.mp3?mediaType=feedmp3</link>
<description>
"PEPFAR/Global Fund at 10 years: Past, Present, and Future" by Stefano M. Bertozzi of University of California Berkeley School of Public Health, Berkeley, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22261.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22261.mp3</guid>	
 
<itunes:summary>Plenary: PEPFAR/Global Fund at 10 years: Past, Present, and Future

"PEPFAR/Global Fund at 10 years: Past, Present, and Future" by Stefano M. Bertozzi of University of California Berkeley School of Public Health, Berkeley, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22264.mp3?mediaType=feedmp3</link>
<description>
"Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV+ Patients" by Markella V. Zanni of Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22264.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22264.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV+ Patients" by Markella V. Zanni of Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22265.mp3?mediaType=feedmp3</link>
<description>
"Arterial Inflammation in HIV as Measured by FDG-PET/CT Is Associated With Splenic Activity" by Priscilla Y. Hsue of Cardiology, University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22265.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22265.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"Arterial Inflammation in HIV as Measured by FDG-PET/CT Is Associated With Splenic Activity" by Priscilla Y. Hsue of Cardiology, University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22266.mp3?mediaType=feedmp3</link>
<description>
"Replicative Senescence of Circulating Osteogenic Cells and Low BMD in Perinatally Infected Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22266.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22266.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"Replicative Senescence of Circulating Osteogenic Cells and Low BMD in Perinatally Infected Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22267.mp3?mediaType=feedmp3</link>
<description>
"High-Dose Vitamin D and Calcium Attenuates Bone Loss With ART Initiation: Results From ACTG A5280" by Edgar T. Overton of University of Alabama School of Medicine, Birmingham, AL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22267.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22267.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"High-Dose Vitamin D and Calcium Attenuates Bone Loss With ART Initiation: Results From ACTG A5280" by Edgar T. Overton of University of Alabama School of Medicine, Birmingham, AL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22268.mp3?mediaType=feedmp3</link>
<description>
"Rosuvastatin Improves Hip Bone Mineral Density But Worsens Insulin Resistance" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22268.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22268.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"Rosuvastatin Improves Hip Bone Mineral Density But Worsens Insulin Resistance" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: CV and Other Complications</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22269.mp3?mediaType=feedmp3</link>
<description>
"Effects of Tesamorelin On Hepatic Fat in HIV Patients: A Randomized, Placebo-Controlled Trial" by Steven Grinspoon of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22269.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22269.mp3</guid>	
 
<itunes:summary>Oral Abstract: CV and Other Complications

"Effects of Tesamorelin On Hepatic Fat in HIV Patients: A Randomized, Placebo-Controlled Trial" by Steven Grinspoon of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22272.mp3?mediaType=feedmp3</link>
<description>
"Moderator" by Mary Kearney of National Cancer Institute, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22272.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22272.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Moderator" by Mary Kearney of National Cancer Institute, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22273.mp3?mediaType=feedmp3</link>
<description>
"Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir" by Afam A. Okoye of Vaccine &amp; Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health &amp; Science University, Beaverton, OR, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22273.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22273.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir" by Afam A. Okoye of Vaccine &amp; Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health &amp; Science University, Beaverton, OR, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22274.mp3?mediaType=feedmp3</link>
<description>
"CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART" by Joseph K. Wong of University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22274.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22274.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART" by Joseph K. Wong of University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22275.mp3?mediaType=feedmp3</link>
<description>
"Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence" by Thor A. Wagner of University of Washington, Seattle, WA, United States and Seattle Children’s Hospital, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22275.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22275.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence" by Thor A. Wagner of University of Washington, Seattle, WA, United States and Seattle Children’s Hospital, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22276.mp3?mediaType=feedmp3</link>
<description>
"Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo" by Gregory M. Laird of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22276.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22276.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo" by Gregory M. Laird of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22277.mp3?mediaType=feedmp3</link>
<description>
"Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy" by Khader Ghneim of VGTI-FL, Port Saint Lucie, FL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22277.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22277.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy" by Khader Ghneim of VGTI-FL, Port Saint Lucie, FL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22278.mp3?mediaType=feedmp3</link>
<description>
"Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control" by Gary Blick of Circle Care Center, Norwalk, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22278.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22278.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control" by Gary Blick of Circle Care Center, Norwalk, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22279.mp3?mediaType=feedmp3</link>
<description>
"Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir" by Kai Deng of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22279.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22279.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir" by Kai Deng of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22280.mp3?mediaType=feedmp3</link>
<description>
"Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART" by Bernard J. Macatangay of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22280.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22280.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART" by Bernard J. Macatangay of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Persistence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22281.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22281.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22281.mp3</guid>	
 
<itunes:summary>Oral Abstract: Persistence

"HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22285.mp3?mediaType=feedmp3</link>
<description>
"Age-Disparate Relationships and HIV Incidence Amongst Rural South Africa Women" by Guy Harling of Global Health and Population, Harvard School of Public Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22285.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22285.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Age-Disparate Relationships and HIV Incidence Amongst Rural South Africa Women" by Guy Harling of Global Health and Population, Harvard School of Public Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22286.mp3?mediaType=feedmp3</link>
<description>
"Introduction of HIV into Stable Heterosexual Couples in Rakai, Uganda Before and After ART" by Mary K. Grabowski of Epidemiology, The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22286.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22286.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Introduction of HIV into Stable Heterosexual Couples in Rakai, Uganda Before and After ART" by Mary K. Grabowski of Epidemiology, The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22287.mp3?mediaType=feedmp3</link>
<description>
"One Year Outcomes Following Community-Based HIV Self-Testing: A Prospective Study in Malawi" by Augustine T. Choko of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22287.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22287.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"One Year Outcomes Following Community-Based HIV Self-Testing: A Prospective Study in Malawi" by Augustine T. Choko of Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22288.mp3?mediaType=feedmp3</link>
<description>
"Community HIV Testing and Linkage To Care Reduces Population Viral Load in South Africa and Uganda" by Ruanne V. Barnabas of Global Health and Medicine, University of Washington, Seattle, WA, United States and Fred Hutchinson Cancer Research Center, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22288.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22288.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Community HIV Testing and Linkage To Care Reduces Population Viral Load in South Africa and Uganda" by Ruanne V. Barnabas of Global Health and Medicine, University of Washington, Seattle, WA, United States and Fred Hutchinson Cancer Research Center, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22289.mp3?mediaType=feedmp3</link>
<description>
"Enhanced HIV Surveillance To Evaluate the National Response To HIV/AIDS in Kenya" by William Maina of National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22289.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22289.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Enhanced HIV Surveillance To Evaluate the National Response To HIV/AIDS in Kenya" by William Maina of National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22290.mp3?mediaType=feedmp3</link>
<description>
"Unequal Benefits From ART: A Growing Male Disadvantage in Life Expectancy in Rural South Africa" by Till Barnighausen of Global Health and Population, Harvard School of Public Health, Boston, MA, United States and Africa Centre for Health and Population Studies, Mtubatuba, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22290.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22290.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Unequal Benefits From ART: A Growing Male Disadvantage in Life Expectancy in Rural South Africa" by Till Barnighausen of Global Health and Population, Harvard School of Public Health, Boston, MA, United States and Africa Centre for Health and Population Studies, Mtubatuba, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22291.mp3?mediaType=feedmp3</link>
<description>
"A New Paradigm for Evaluating the HIV Care Cascade" by Margaret L. McNairy of ICAP Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22291.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22291.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"A New Paradigm for Evaluating the HIV Care Cascade" by Margaret L. McNairy of ICAP Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22292.mp3?mediaType=feedmp3</link>
<description>
"Moderate HIV Incidence and High ART Coverage in Rural Kwazulu-Natal: First Population-Based Survey" by Helena Huerga of Epicentre, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22292.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22292.mp3</guid>	
 
<itunes:summary>Oral Abstract: Antiretroviral Scale-Up in Sub-Saharan Africa: Challenges and Opportunities

"Moderate HIV Incidence and High ART Coverage in Rural Kwazulu-Natal: First Population-Based Survey" by Helena Huerga of Epicentre, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22297.mp3?mediaType=feedmp3</link>
<description>
"Cryo-EM Structures of the HIV-1 Env Trimer Reveal the Full Extent of Neutralizing Antibody Epitopes" by Andrew B. Ward of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22297.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22297.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Cryo-EM Structures of the HIV-1 Env Trimer Reveal the Full Extent of Neutralizing Antibody Epitopes" by Andrew B. Ward of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22298.mp3?mediaType=feedmp3</link>
<description>
"Immunogenicity of Cleaved, Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits" by John P. Moore of Microbiology/Immunology, Weill Medical College, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22298.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22298.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Immunogenicity of Cleaved, Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits" by John P. Moore of Microbiology/Immunology, Weill Medical College, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22299.mp3?mediaType=feedmp3</link>
<description>
"Identification of a New Neutralization Target at the N262/N448 Glycosylation Sites On HIV-1 gp120" by Xueling Wu of Aaron Diamond AIDS Research Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22299.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22299.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Identification of a New Neutralization Target at the N262/N448 Glycosylation Sites On HIV-1 gp120" by Xueling Wu of Aaron Diamond AIDS Research Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22300.mp3?mediaType=feedmp3</link>
<description>
"CD169 Mediates HIV-1 Evasion From Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells" by Hisashi Akiyama of Microbiology, Boston University School of Medicine, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22300.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22300.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"CD169 Mediates HIV-1 Evasion From Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells" by Hisashi Akiyama of Microbiology, Boston University School of Medicine, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22301.mp3?mediaType=feedmp3</link>
<description>
"Tetherin Antagonism by Vpu Protects HIV-Infected Cells From ADCC" by Juan F. Arias of Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22301.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22301.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Tetherin Antagonism by Vpu Protects HIV-Infected Cells From ADCC" by Juan F. Arias of Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22302.mp3?mediaType=feedmp3</link>
<description>
"HIV Nef and Vpu Protect HIV-infected CD4+ T Cells From ADCC Through Downmodulation of CD4 and BST2" by Tram N. Q. Pham of Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22302.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22302.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"HIV Nef and Vpu Protect HIV-infected CD4+ T Cells From ADCC Through Downmodulation of CD4 and BST2" by Tram N. Q. Pham of Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22303.mp3?mediaType=feedmp3</link>
<description>
"Identification of HIV-infected CD4+ T Cells Using HIV RNA and Broadly Neutralizing Antibodies" by Joseph P. Casazza of Immunology Laboratory, NIAID, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22303.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22303.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Identification of HIV-infected CD4+ T Cells Using HIV RNA and Broadly Neutralizing Antibodies" by Joseph P. Casazza of Immunology Laboratory, NIAID, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22304.mp3?mediaType=feedmp3</link>
<description>
"Type I Interferon Signaling Is Critical for Early Control of Immune System Damage" by Netanya G. Sandler of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22304.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22304.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"Type I Interferon Signaling Is Critical for Early Control of Immune System Damage" by Netanya G. Sandler of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22305.mp3?mediaType=feedmp3</link>
<description>
"miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo" by Mohamed Abdel-Mohsen of Medicine, University of California, San Francisco, San Francisco, CA, United States and Blood Systems Research Institute, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22305.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22305.mp3</guid>	
 
<itunes:summary>Oral Abstract: Interferon and Antibody at the Interface of Innate and Adaptive Immunity to HIV

"miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo" by Mohamed Abdel-Mohsen of Medicine, University of California, San Francisco, San Francisco, CA, United States and Blood Systems Research Institute, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22307.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Thomas S. Uldrick of National Cancer Institute, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22307.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22307.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Discussion Leader" by Thomas S. Uldrick of National Cancer Institute, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22308.mp3?mediaType=feedmp3</link>
<description>
"Guidelines On Kaposi’s Sarcoma Treatment: Results From Two Cochrane Systematic Reviews" by Esther E. Freeman of Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22308.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22308.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Guidelines On Kaposi’s Sarcoma Treatment: Results From Two Cochrane Systematic Reviews" by Esther E. Freeman of Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22309.mp3?mediaType=feedmp3</link>
<description>
"Kaposi Sarcoma in the Era of Combination Antiretroviral Therapy" by Matthias Egger of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22309.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22309.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Kaposi Sarcoma in the Era of Combination Antiretroviral Therapy" by Matthias Egger of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22310.mp3?mediaType=feedmp3</link>
<description>
"Randomized Trial of Protease Inhibitor-Based Antiretroviral Therapy for Kaposi Sarcoma in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22310.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22310.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Randomized Trial of Protease Inhibitor-Based Antiretroviral Therapy for Kaposi Sarcoma in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22311.mp3?mediaType=feedmp3</link>
<description>
"The Effect of Protease Inhibitor Use On Kaposi Sarcoma Incidence in a cART-Experienced Cohort" by Elizabeth Chiao of Baylor College of Medicine, Houston, TX, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22311.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22311.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"The Effect of Protease Inhibitor Use On Kaposi Sarcoma Incidence in a cART-Experienced Cohort" by Elizabeth Chiao of Baylor College of Medicine, Houston, TX, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22312.mp3?mediaType=feedmp3</link>
<description>
"Indoleamine 2,3-Dioxygenase (IDO) Activity as a Determinant of Kaposi Sarcoma in Africa" by Helen Byakwaga of University of California San Francisco, San Francisco, CA, United States and Mbarara University of Science and Technology, Mbarara, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22312.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22312.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Indoleamine 2,3-Dioxygenase (IDO) Activity as a Determinant of Kaposi Sarcoma in Africa" by Helen Byakwaga of University of California San Francisco, San Francisco, CA, United States and Mbarara University of Science and Technology, Mbarara, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22313.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22313.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22313.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22314.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Marshall J. Glesby of Weill Cornell Medical College, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22314.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22314.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Discussion Leader" by Marshall J. Glesby of Weill Cornell Medical College, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22315.mp3?mediaType=feedmp3</link>
<description>
"HIV Infection and Related Biomarkers Are Independent Risk Factors for Radiographic Emphysema" by Engi F. Attia of Medicine, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22315.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22315.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"HIV Infection and Related Biomarkers Are Independent Risk Factors for Radiographic Emphysema" by Engi F. Attia of Medicine, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22316.mp3?mediaType=feedmp3</link>
<description>
"Factors Associated With Chronic Obstructive Pulmonary Disease in a High-Risk HIV-Infected Cohort" by Alain Makinson of Infectious and Tropical Diseases Department, University Hospital Montpellier 1, UMI 233, Montpellier, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22316.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22316.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Factors Associated With Chronic Obstructive Pulmonary Disease in a High-Risk HIV-Infected Cohort" by Alain Makinson of Infectious and Tropical Diseases Department, University Hospital Montpellier 1, UMI 233, Montpellier, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22317.mp3?mediaType=feedmp3</link>
<description>
"HIV Infection Increases Risk of Acute Exacerbations of COPD" by Allison A. Lambert of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22317.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22317.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"HIV Infection Increases Risk of Acute Exacerbations of COPD" by Allison A. Lambert of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22318.mp3?mediaType=feedmp3</link>
<description>
"Association of HIV Infection and Immune Activation With Decline in Lung Function" by Kristina Crothers of Department of Medicine, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22318.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22318.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Association of HIV Infection and Immune Activation With Decline in Lung Function" by Kristina Crothers of Department of Medicine, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22319.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22319.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22319.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22320.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Christine M. Rousseau of Bill and Melinda Gates Foundation, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22320.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22320.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Discussion Leader" by Christine M. Rousseau of Bill and Melinda Gates Foundation, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22321.mp3?mediaType=feedmp3</link>
<description>
"Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens" by Erin K. Rottinghaus of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22321.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22321.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens" by Erin K. Rottinghaus of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22322.mp3?mediaType=feedmp3</link>
<description>
"Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US" by Andrew F. Longosz of Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22322.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22322.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US" by Andrew F. Longosz of Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22323.mp3?mediaType=feedmp3</link>
<description>
"The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda" by Andrew F. Longosz of NIAID, National Insitutes of Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22323.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22323.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda" by Andrew F. Longosz of NIAID, National Insitutes of Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22324.mp3?mediaType=feedmp3</link>
<description>
"Independent Evaluation of Predicate Incidence Assays for HIV Surveillance" by Alex Welte of The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22324.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22324.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Independent Evaluation of Predicate Incidence Assays for HIV Surveillance" by Alex Welte of The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22325.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22325.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22325.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22326.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Paula M. Cannon of University of Southern California, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22326.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22326.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Discussion Leader" by Paula M. Cannon of University of Southern California, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22327.mp3?mediaType=feedmp3</link>
<description>
"Impact of Systemic Cytotoxic Chemotherapy for Malignancies On HIV-1 Reservoir Persistence" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22327.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22327.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Impact of Systemic Cytotoxic Chemotherapy for Malignancies On HIV-1 Reservoir Persistence" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22328.mp3?mediaType=feedmp3</link>
<description>
"Dynamics of HSPC Repopulation in Nonhuman Primates Revealed by a Decade-Long Clonal Tracking" by Sanggu Kim of University of California, Los Angeles, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22328.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22328.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Dynamics of HSPC Repopulation in Nonhuman Primates Revealed by a Decade-Long Clonal Tracking" by Sanggu Kim of University of California, Los Angeles, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22329.mp3?mediaType=feedmp3</link>
<description>
"Targeting SIV Reservoirs via Autologous Hematopoietic Stem Cell Transplant in Rhesus Macaques" by Maud Mavigner of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22329.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22329.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Targeting SIV Reservoirs via Autologous Hematopoietic Stem Cell Transplant in Rhesus Macaques" by Maud Mavigner of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22330.mp3?mediaType=feedmp3</link>
<description>
"Modeling Functional Cure of HIV in Nonhuman Primates Using Gene-Modified Hematopoietic Stem Cells" by Hans-Peter Kiem of Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22330.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22330.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Modeling Functional Cure of HIV in Nonhuman Primates Using Gene-Modified Hematopoietic Stem Cells" by Hans-Peter Kiem of Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22331.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22331.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22331.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22333.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Scott L. Letendre of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22333.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22333.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Discussion Leader" by Scott L. Letendre of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22334.mp3?mediaType=feedmp3</link>
<description>
"CNS Outcomes of cART vs. cART plus Maraviroc and Raltegravir Intensification During Acute HIV" by James L. K. Fletcher of SEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22334.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22334.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"CNS Outcomes of cART vs. cART plus Maraviroc and Raltegravir Intensification During Acute HIV" by James L. K. Fletcher of SEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22335.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 RNA Detection in CSF in ART-Treated Subjects With Incomplete Viral Suppression in Plasma" by Sam Nightingale of Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22335.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22335.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"HIV-1 RNA Detection in CSF in ART-Treated Subjects With Incomplete Viral Suppression in Plasma" by Sam Nightingale of Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22336.mp3?mediaType=feedmp3</link>
<description>
"CSF Viral Escape in Patients Without Neurological Disorders: Prevalence and Associated Factors" by Carmela Pinnetti of National Institute for Infectious Disease, Rome, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22336.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22336.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"CSF Viral Escape in Patients Without Neurological Disorders: Prevalence and Associated Factors" by Carmela Pinnetti of National Institute for Infectious Disease, Rome, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22337.mp3?mediaType=feedmp3</link>
<description>
"Cerebrospinal Fluid Viral Blips and Persistent Escape in HIV-Infected Patients On ART" by Arvid Eden of University of Gothenburg, Gothenburg, Sweden
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22337.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22337.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Cerebrospinal Fluid Viral Blips and Persistent Escape in HIV-Infected Patients On ART" by Arvid Eden of University of Gothenburg, Gothenburg, Sweden

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22338.mp3?mediaType=feedmp3</link>
<description>
"Mitochondrial DNA Is Associated With Inflammation and Neurocognitive Deficits in HIV Infection" by Josué Pérez-Santiago of Medicine, University of California San Diego, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22338.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22338.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Mitochondrial DNA Is Associated With Inflammation and Neurocognitive Deficits in HIV Infection" by Josué Pérez-Santiago of Medicine, University of California San Diego, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22339.mp3?mediaType=feedmp3</link>
<description>
"Early Monocyte Inflammation Among Treatment-Naïve Acute HIV-Infected Thai Subjects" by Lishomwa C. Ndhlovu of Hawaii Center for AIDS, University of Hawaii, Honolulu, HI, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22339.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22339.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Early Monocyte Inflammation Among Treatment-Naïve Acute HIV-Infected Thai Subjects" by Lishomwa C. Ndhlovu of Hawaii Center for AIDS, University of Hawaii, Honolulu, HI, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22340.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22340.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22340.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Interferon: Whatever Turns You On</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22341.mp3?mediaType=feedmp3</link>
<description>
"Convener" by Nina Bhardwaj of Icahn School of Medicine at Mount Sinai, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22341.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22341.mp3</guid>	
 
<itunes:summary>Symposium: Interferon: Whatever Turns You On

"Convener" by Nina Bhardwaj of Icahn School of Medicine at Mount Sinai, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Interferon: Whatever Turns You On</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22343.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Evades Innate Immune Recognition Through Specific Co-Factor Recruitment" by Greg J. Towers of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22343.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22343.mp3</guid>	
 
<itunes:summary>Symposium: Interferon: Whatever Turns You On

"HIV-1 Evades Innate Immune Recognition Through Specific Co-Factor Recruitment" by Greg J. Towers of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Interferon: Whatever Turns You On</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22344.mp3?mediaType=feedmp3</link>
<description>
"Interferon Treatments for Chronic Hepatitis C" by Markus H. Heim of University Hospital Basel, Basel, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22344.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22344.mp3</guid>	
 
<itunes:summary>Symposium: Interferon: Whatever Turns You On

"Interferon Treatments for Chronic Hepatitis C" by Markus H. Heim of University Hospital Basel, Basel, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Interferon: Whatever Turns You On</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22345.mp3?mediaType=feedmp3</link>
<description>
"Perturbing Interferon Signaling in SIV Infection" by Daniel C. Douek of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22345.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22345.mp3</guid>	
 
<itunes:summary>Symposium: Interferon: Whatever Turns You On

"Perturbing Interferon Signaling in SIV Infection" by Daniel C. Douek of National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Interferon: Whatever Turns You On</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22346.mp3?mediaType=feedmp3</link>
<description>
"Type 1 Interferon-Mediated Selective Pressure On HIV-1 Transmission" by Persephone Borrow of University of Oxford, Oxford, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22346.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22346.mp3</guid>	
 
<itunes:summary>Symposium: Interferon: Whatever Turns You On

"Type 1 Interferon-Mediated Selective Pressure On HIV-1 Transmission" by Persephone Borrow of University of Oxford, Oxford, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22350.mp3?mediaType=feedmp3</link>
<description>
"Treatment of Pregnant and Breast-Feeding Women: Evidence and Rationale for Option B+" by Saeed Ahmed of Baylor College of Medicine, Lilongwe, Malawi
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22350.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22350.mp3</guid>	
 
<itunes:summary>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants

"Treatment of Pregnant and Breast-Feeding Women: Evidence and Rationale for Option B+" by Saeed Ahmed of Baylor College of Medicine, Lilongwe, Malawi

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22351.mp3?mediaType=feedmp3</link>
<description>
"Achievements and Challenges With Option B+ Implementation in the Field To Date" by Edward Bitarakwate of Elizabeth Glaser Pediatric AIDS Foundation, Kampala, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22351.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22351.mp3</guid>	
 
<itunes:summary>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants

"Achievements and Challenges With Option B+ Implementation in the Field To Date" by Edward Bitarakwate of Elizabeth Glaser Pediatric AIDS Foundation, Kampala, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22352.mp3?mediaType=feedmp3</link>
<description>
"No Free Rides: Consequences of Fetal &amp; Infant ARV Exposure Among Children Remaining HIV Uninfected" by Kathleen M. Powis of Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22352.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22352.mp3</guid>	
 
<itunes:summary>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants

"No Free Rides: Consequences of Fetal &amp; Infant ARV Exposure Among Children Remaining HIV Uninfected" by Kathleen M. Powis of Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22353.mp3?mediaType=feedmp3</link>
<description>
"Treatment of HIV-Infected Newborns: Why, When, and What To Start?" by Ellen G. Chadwick of Northwestern University, Feinberg School of Medicine, Chicago, IL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22353.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22353.mp3</guid>	
 
<itunes:summary>Symposium: The Road to Elimination: Preventing and Treating HIV Infection in Infants

"Treatment of HIV-Infected Newborns: Why, When, and What To Start?" by Ellen G. Chadwick of Northwestern University, Feinberg School of Medicine, Chicago, IL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Intimate Infections: What’s Love Got to Do With It?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22357.mp3?mediaType=feedmp3</link>
<description>
"Oral Human Papillomavirus (HPV): Epidemiology and Role in Oropharyngeal Cancer" by Gypsyamber D'Souza of The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22357.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22357.mp3</guid>	
 
<itunes:summary>Symposium: Intimate Infections: What’s Love Got to Do With It?

"Oral Human Papillomavirus (HPV): Epidemiology and Role in Oropharyngeal Cancer" by Gypsyamber D'Souza of The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Intimate Infections: What’s Love Got to Do With It?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22358.mp3?mediaType=feedmp3</link>
<description>
"Bacterial Vaginosis" by Landon Myer of University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22358.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22358.mp3</guid>	
 
<itunes:summary>Symposium: Intimate Infections: What’s Love Got to Do With It?

"Bacterial Vaginosis" by Landon Myer of University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Intimate Infections: What’s Love Got to Do With It?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22359.mp3?mediaType=feedmp3</link>
<description>
"Outbreak of Invasive Meningococcal Disease Among Men Who Have Sex With Men — New York City, 2010-2013" by Alison Ridpath of New York City Department of Health and Mental Hygiene, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22359.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22359.mp3</guid>	
 
<itunes:summary>Symposium: Intimate Infections: What’s Love Got to Do With It?

"Outbreak of Invasive Meningococcal Disease Among Men Who Have Sex With Men — New York City, 2010-2013" by Alison Ridpath of New York City Department of Health and Mental Hygiene, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Symposium: Intimate Infections: What’s Love Got to Do With It?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22360.mp3?mediaType=feedmp3</link>
<description>
"Lymphogranuloma venereum" by David A. Lewis of National Institute for Communicable Diseases, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22360.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22360.mp3</guid>	
 
<itunes:summary>Symposium: Intimate Infections: What’s Love Got to Do With It?

"Lymphogranuloma venereum" by David A. Lewis of National Institute for Communicable Diseases, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


	
 
</channel>
</rss>
